News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sihuan Pharmaceutical Holdings Group Ltd. Acquires TCM Cardiovascular Drug Maker for $120 Million


6/23/2011 11:34:55 AM

June 23, 2011 -- Sihuan Pharmaceutical paid 775 million RMB ($120 million) to acquire two China drug companies, Vinise Pharma and Hainan Litzman Pharma. The transaction adds to Sihuan’s portfolio of treatments for cardio-cerebral vascular diseases by taking the company into TCM preparations – Vinise Pharma’s specialty – for the first time. Vinise also has expertise in large-volume injections, another new area for Sihuan. More details....

Stock Symbol: (HK: 0460)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES